Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Pharmaceuticals - North America (NAFTA) Industry Guide

Published by: Datamonitor

Published: Apr. 1, 2009 - 97 Pages


Table of Contents


CHAPTER 1 INTRODUCTION
1.1 What is this report about?
1.2 Who is the target reader?
1.3 How to use this report
1.4 Definitions
CHAPTER 2 NAFTA COUNTRIES PHARMACEUTICALS INDUSTRY OUTLOOK
CHAPTER 3 PHARMACEUTICALS IN UNITED STATES
3.1 Market Overview
3.2 Market Value
3.3 Market Segmentation I
3.4 Market Segmentation II
3.5 Market Share
3.6 Five Forces Analysis
3.7 Leading Companies
3.8 Market Forecasts
3.9 Macroeconomic Indicators
CHAPTER 4 PHARMACEUTICALS IN MEXICO
4.1 Market Overview
4.2 Market Value
4.3 Market Segmentation I
4.4 Market Segmentation II
4.5 Market Share
4.6 Five Forces analysis
4.7 Leading Companies
4.8 Market Forecasts
4.9 Macroeconomic Indicators
CHAPTER 5 PHARMACEUTICALS IN CANADA
5.1 Market Overview
5.2 Market Value
5.3 Market Segmentation I
5.4 Market Segmentation II
5.5 Market Share
5.6 Five Forces Analysis
5.7 Leading Companies
5.8 Market Forecasts
5.9 Macroeconomic Indicators
CHAPTER 6 APPENDIX
6.1 Data Research Methodology
LIST OF TABLES
Table 1: NAFTA countries Pharmaceuticals industry, revenue ($bn) 2004-2013
Table 2: NAFTA countries Pharmaceuticals industry, revenue ($ bn) 2004-2008(e)
Table 3: NAFTA countries Pharmaceuticals industry forecast, revenue ($ bn) 2008-2013
Table 4: United States Pharmaceuticals Market Value: $ billion, 2004-2008
Table 5: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 6: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 7: United States Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Table 8: Key Facts: Pfizer Inc
Table 9: Key Financials: Pfizer Inc
Table 10: Key Facts: GlaxoSmithKline Plc
Table 11: Key Financials: GlaxoSmithKline Plc
Table 12: Key Facts: Merck & Co., Inc.
Table 13: Key Financials: Merck & Co., Inc.
Table 14: Key Facts: Johnson & Johnson
Table 15: Key Financials: Johnson & Johnson
Table 16: United States Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 17: United States Size of Population (million) , 2004-2008
Table 18: United States GDP (Constant 2000 Prices, $ billion), 2004-2008
Table 19: United States Inflation, 2004-2008
Table 20: Mexico Pharmaceuticals Market Value: $ billion, 2004-2008
Table 21: Mexico Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 22: Mexico Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 23: Mexico Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Table 24: Key Facts: Pfizer Inc
Table 25: Key Financials: Pfizer Inc
Table 26: Key Facts: GlaxoSmithKline Plc
Table 27: Key Financials: GlaxoSmithKline Plc
Table 28: Key Facts: Eli Lilly and Company
Table 29: Key Financials: Eli Lilly and Company
Table 30: Key Facts: Sanofi-Aventis SA
Table 31: Key Financials: Sanofi-Aventis SA
Table 32: Mexico Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 33: Mexico Size of Population (million) , 2004-2008
Table 34: Mexico GDP (Constant 2000 Prices, $ billion), 2004-2008
Table 35: Mexico Inflation, 2004-2008
Table 36: Mexico Exchange Rate, 2004-2008
Table 37: Canada Pharmaceuticals Market Value: $ billion, 2004-2008
Table 38: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Table 39: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Table 40: Canada Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Table 41: Key Facts: Pfizer Inc
Table 42: Key Financials: Pfizer Inc
Table 43: Key Facts: AstraZeneca PLC
Table 44: Key Financials: AstraZeneca PLC
Table 45: Key Facts: Apotex, Inc.
Table 46: Key Facts: Johnson & Johnson
Table 47: Key Financials: Johnson & Johnson
Table 48: Canada Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Table 49: Canada Size of Population (million) , 2004-2008
Table 50: Canada GDP (Constant 2000 Prices, $ billion), 2004-2008
Table 51: Canada Inflation, 2004-2008
Table 52: Canada Exchange Rate, 2004-2008
LIST OF FIGURES
Figure 1: NAFTA countries Pharmaceuticals industry, revenue ($bn) 2004-2013
Figure 2: NAFTA countries Pharmaceuticals industry, revenue ($ bn) 2004-2008(e)
Figure 3: NAFTA countries Pharmaceuticals industry forecast, revenue ($ bn) 2008-2013
Figure 4: United States Pharmaceuticals Market Value: $ billion, 2004-2008
Figure 5: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 6: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 7: United States Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Figure 8: Forces Driving Competition in the Pharmaceutical Market in the US
Figure 9: Drivers of Buyer Power in the Pharmaceutical Market in the US
Figure 10: Drivers of Supplier Power in the Pharmaceutical Market in the US
Figure 11: Factors Influencing the Likelihood of New Entrants in the Pharmaceutical Market in the US
Figure 12: Factors Influencing the Threat of Substitutes in the Pharmaceutical Market in the US
Figure 13: Drivers of Degree of Rivalry in the Pharmaceutical Market in the US
Figure 14: Revenues & Profitability: Pfizer Inc
Figure 15: Revenues & Profitability: GlaxoSmithKline Plc
Figure 16: Revenues & Profitability: Merck & Co., Inc.
Figure 17: Revenues & Profitability: Johnson & Johnson
Figure 18: United States Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 19: Mexico Pharmaceuticals Market Value: $ billion, 2004-2008
Figure 20: Mexico Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 21: Mexico Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 22: Mexico Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Figure 23: Forces Driving Competition in the Pharmaceutical Market in Mexico
Figure 24: Drivers of Buyer Power in the Pharmaceutical Market in Mexico
Figure 25: Drivers of Supplier Power in the Pharmaceutical Market in Mexico
Figure 26: Factors Influencing the Likelihood of New Entrants in the Pharmaceutical Market in Mexico
Figure 27: Factors Influencing the Threat of Substitutes in the Pharmaceutical Market in Mexico
Figure 28: Drivers of Degree of Rivalry in the Pharmaceutical Market in Mexico
Figure 29: Revenues & Profitability: Pfizer Inc
Figure 30: Revenues & Profitability: GlaxoSmithKline Plc
Figure 31: Revenues & Profitability: Eli Lilly and Company
Figure 32: Revenues & Profitability: Sanofi-Aventis SA
Figure 33: Mexico Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
Figure 34: Canada Pharmaceuticals Market Value: $ billion, 2004-2008
Figure 35: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
Figure 36: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
Figure 37: Canada Pharmaceuticals Market Share: % Share, by Value, 2008(e)
Figure 38: Forces Driving Competition in the Pharmaceuticals Market in Canada
Figure 39: Drivers of Buyer Power in the Pharmaceuticals Market in Canada
Figure 40: Drivers of Supplier Power in the Pharmaceuticals Market in Canada
Figure 41: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Canada
Figure 42: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Canada
Figure 43: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Canada
Figure 44: Revenues & Profitability: Pfizer Inc
Figure 45: Revenues & Profitability: AstraZeneca PLC
Figure 46: Revenues & Profitability: Johnson & Johnson
Figure 47: Canada Pharmaceuticals Market Value Forecast: $ billion, 2008-2013

Abstract

Datamonitor's Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Scope of the Report
  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Compares data from the US, Canada and Mexico, alongside individual chapters on each country. .
  • Includes a five-year forecast of the industry
Highlights

The NAFTA pharmaceuticals market reaches a value of $303.5 billion in 2007.

The US is the leading country among the NAFTA bloc, with market revenues of $271.2 billion in 2007

Mexico was the fastest growing country, with a CAGR of 10.2% over the 2004-2007 period.

Why you should buy this report
  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research
Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2010